<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "apixaban tab">
<dose><value>2.5</value>
<value>5</value>
<value>10</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>2.5 mg</value>
<value>5 mg</value>
</strength>
<frequency><value>BID</value>
</frequency>
<instruction><value>Administer for 7 days, followed by 5 mg BID.</value>
</instruction>
<volume></volume>
<units><value>mg</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>VTE prevention post-elective hip and knee replacement surgery.</value>
<value>Stroke prevention in patients with Atrial Fibrillation.</value>
<value>Stroke prevention in patients with Atrial Fibrillation, if meeting 2 of body weight 60kg or less, age of 80 years or greater or serum creatinine is 133 umol or greater.</value>
<value>DVT/PE treatment</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=4921</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6241</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions, Usage guidelines.</value>
</AHSFormularyStatus>
<AHFSName><value>Antithrombotic Agents, Anticoagulants</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>